/ /

  • linkedin
  • Increase Font
  • Sharebar

    New glaucoma devices bring new dimension of treatment


    Three multicenter prospective studies have treated more than 1,500 patients. Patients show nearly a 30% reduction in IOP at 1 year with minimal safety concerns. The device is available in the EU.

    “The eyes are typically quiet after treatment,” said CEO Dietrich Wolf, PhD. “We never saw any major adverse events and visual acuity stays as it was before treatment.”

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results